Related Experiment Videos
Regional adenosine attenuates postischemic spinal cord injury
P S Seibel1, P Theodore, I L Kron
1Department of Surgery, University of Virginia Health Sciences Center, Charlottesville 22908.
Journal of Vascular Surgery
|August 1, 1993
Summary
Regional adenosine perfusion significantly reduced spinal cord injury after aortic occlusion in rabbits. This finding suggests adenosine as a potential neuroprotective agent to prevent paraplegia during aortic surgeries.
Area of Science:
- Cardiovascular Surgery
- Neuroprotection
- Experimental Medicine
Background:
- Thoracic and thoracoabdominal aortic surgeries carry a high risk of postoperative paraplegia (20-30%).
- Current strategies to mitigate paraplegia include hypothermia, barbiturates, and shunts.
- Spinal cord protection strategies aim to reduce energy demands or improve blood flow.
Purpose of the Study:
- To investigate the hypothesis that spinal cord perfusion with hypothermic solutions or adenosine can prevent or reduce paraplegia.
- To evaluate the efficacy of regional hypothermia and adenosine in preventing ischemic spinal cord injury.
Main Methods:
- New Zealand white rabbits underwent 40 minutes of infrarenal aortic isolation.
- Control group: aortic occlusion without protection.
- Experimental groups: aortic cross-clamping with regional hypothermia perfusion (Group I), systemic adenosine (Group II), or regional high-dose adenosine perfusion (Group III).
Main Results:
- Neurologic function was assessed using the Tarlov scale.
- Nonparaplegic animals in Group I (regional hypothermia) had a mean Tarlov score of 1.5.
- Nonparaplegic animals in Group III (regional adenosine) showed a significantly higher mean Tarlov score of 3.4.
- Histologic examination revealed no significant differences in spinal cord tissue between groups.
Conclusions:
- Regional adenosine administration effectively attenuates ischemic injury following aortic occlusion in this rabbit model.
- These findings support the potential of regional adenosine perfusion as a neuroprotective strategy against paraplegia.
- Further research may explore optimizing adenosine delivery for clinical application.